Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Goodman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|December 13, 2016
Lifeline for refugee scholarsAllan Goodman
Marine Drugs|April 2, 2014
Structure activity relationship of brevenal hydrazide derivativesAllan Goodman, Jennifer R McCall, Henry M Jacocks, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's diseaseJames B Koprich, Susan H Fox, Tom H Johnston, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stabilityIan Sellitto, Bertrand Le Bourdonnec, Karin Worm, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|December 13, 2016
Lifeline for refugee scholarsAllan Goodman
Marine Drugs|April 2, 2014
Structure activity relationship of brevenal hydrazide derivativesAllan Goodman, Jennifer R McCall, Henry M Jacocks, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's diseaseJames B Koprich, Susan H Fox, Tom H Johnston, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stabilityIan Sellitto, Bertrand Le Bourdonnec, Karin Worm, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Pageof 1